1	Biphasic	biphasic	_	_	_	_	_	_	_
2	control	control	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	nuclear	nuclear	_	_	_	_	_	_	_
5	factor-kappa	factor-kappa	_	_	_	_	_	_	_
6	B	B	_	_	_	_	_	_	_
7	activation	activation	_	_	_	_	_	_	_
8	by	by	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	T	t	_	_	_	_	_	_	_
11	cell	cell	_	_	_	_	_	_	_
12	receptor	receptor	_	_	_	_	_	_	_
13	complex	complex	_	_	_	_	_	_	_
14	:	:	_	_	_	_	_	_	_
15	role	role	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	tumor	tumor	_	_	_	_	_	_	_
18	necrosis	necrosis	_	_	_	_	_	_	_
19	factor	factor	_	_	_	_	_	_	_
20	alpha	alpha	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	regulation	regulation	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	nuclear	nuclear	_	_	_	_	_	_	_
5	factor	factor	_	_	_	_	_	_	_
6	(	(	_	_	_	_	_	_	_
7	NF)-kappa	NF)-kappa	_	_	_	_	_	_	_
8	B	B	_	_	_	_	_	_	_
9	activation	activation	_	_	_	_	_	_	_
10	by	by	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	T	t	_	_	_	_	_	_	_
13	cell	cell	_	_	_	_	_	_	_
14	receptor	receptor	_	_	_	_	_	_	_
15	(	(	_	_	_	_	_	_	_
16	TcR)/CD3	tcr)/cd3	_	_	_	_	_	_	_
17	complex	complex	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	primary	primary	_	_	_	_	_	_	_
20	human	human	_	_	_	_	_	_	_
21	T	t	_	_	_	_	_	_	_
22	cells	cell	_	_	_	_	_	_	_
23	has	have	_	_	_	_	_	_	_
24	been	be	_	_	_	_	_	_	_
25	studied	study	_	_	_	_	_	_	_
26	at	at	_	_	_	_	_	_	_
27	various	various	_	_	_	_	_	_	_
28	times	time	_	_	_	_	_	_	_
29	after	after	_	_	_	_	_	_	_
30	activation	activation	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	Only	only	_	_	_	_	_	_	_
2	p50	p50	_	_	_	_	_	_	_
3	NF-kappa	NF-kappa	_	_	_	_	_	_	_
4	B	B	_	_	_	_	_	_	_
5	protein	protein	_	_	_	_	_	_	_
6	bound	bind	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	kappa	kappa	_	_	_	_	_	_	_
9	B	B	_	_	_	_	_	_	_
10	element	element	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	interleukin-2	interleukin-2	_	_	_	_	_	_	_
13	receptor	receptor	_	_	_	_	_	_	_
14	(	(	_	_	_	_	_	_	_
15	IL-2R	IL-2R	_	_	_	_	_	_	_
16	)	)	_	_	_	_	_	_	_
17	alpha	alpha	_	_	_	_	_	_	_
18	chain	chain	_	_	_	_	_	_	_
19	promoter	promoter	_	_	_	_	_	_	_
20	on	on	_	_	_	_	_	_	_
21	resting	rest	_	_	_	_	_	_	_
22	T	t	_	_	_	_	_	_	_
23	cells	cell	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	immediately	immediately	_	_	_	_	_	_	_
4	after	after	_	_	_	_	_	_	_
5	TcR/CD3	tcr/cd3	_	_	_	_	_	_	_
6	cross-linking	cross-linking	_	_	_	_	_	_	_
7	(	(	_	_	_	_	_	_	_
8	after	after	_	_	_	_	_	_	_
9	approximately	approximately	_	_	_	_	_	_	_
10	1	1	_	_	_	_	_	_	_
11	h	h	_	_	_	_	_	_	_
12	;	;	_	_	_	_	_	_	_
13	immediate	immediate	_	_	_	_	_	_	_
14	)	)	_	_	_	_	_	_	_
15	binding	binding	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	p50.p65	p50.p65	_	_	_	_	_	_	_
18	heterodimers	heterodimer	_	_	_	_	_	_	_
19	was	be	_	_	_	_	_	_	_
20	observed.	observed.	_	_	_	_	_	_	_
21	p50.c-rel	p50.c-rel	_	_	_	_	_	_	_
22	heterodimers	heterodimer	_	_	_	_	_	_	_
23	were	be	_	_	_	_	_	_	_
24	also	also	_	_	_	_	_	_	_
25	detected	detect	_	_	_	_	_	_	_
26	bound	bind	_	_	_	_	_	_	_
27	to	to	_	_	_	_	_	_	_
28	this	this	_	_	_	_	_	_	_
29	sequence	sequence	_	_	_	_	_	_	_
30	at	at	_	_	_	_	_	_	_
31	early	early	_	_	_	_	_	_	_
32	time	time	_	_	_	_	_	_	_
33	points	point	_	_	_	_	_	_	_
34	(	(	_	_	_	_	_	_	_
35	7-16	7-16	_	_	_	_	_	_	_
36	h	h	_	_	_	_	_	_	_
37	;	;	_	_	_	_	_	_	_
38	early	early	_	_	_	_	_	_	_
39	)	)	_	_	_	_	_	_	_
40	,	,	_	_	_	_	_	_	_
41	and	and	_	_	_	_	_	_	_
42	both	both	_	_	_	_	_	_	_
43	remained	remain	_	_	_	_	_	_	_
44	active	active	_	_	_	_	_	_	_
45	at	at	_	_	_	_	_	_	_
46	later	late	_	_	_	_	_	_	_
47	time	time	_	_	_	_	_	_	_
48	points	point	_	_	_	_	_	_	_
49	(	(	_	_	_	_	_	_	_
50	40	40	_	_	_	_	_	_	_
51	h	h	_	_	_	_	_	_	_
52	;	;	_	_	_	_	_	_	_
53	late	late	_	_	_	_	_	_	_
54	)	)	_	_	_	_	_	_	_
55	after	after	_	_	_	_	_	_	_
56	activation	activation	_	_	_	_	_	_	_
57	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	regulation	regulation	_	_	_	_	_	_	_
3	takes	take	_	_	_	_	_	_	_
4	place	place	_	_	_	_	_	_	_
5	mainly	mainly	_	_	_	_	_	_	_
6	at	at	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	level	level	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	nuclear	nuclear	_	_	_	_	_	_	_
11	translocation	translocation	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	p65	p65	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	c-rel	c-rel	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	at	at	_	_	_	_	_	_	_
18	immediate	immediate	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	early	early	_	_	_	_	_	_	_
21	time	time	_	_	_	_	_	_	_
22	points	point	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	Activation	Activation	_	_	_	_	_	_	_
2	also	also	_	_	_	_	_	_	_
3	induced	induce	_	_	_	_	_	_	_
4	c-rel	c-rel	_	_	_	_	_	_	_
5	and	and	_	_	_	_	_	_	_
6	p105/p50	p105/p50	_	_	_	_	_	_	_
7	mRNA	mrna	_	_	_	_	_	_	_
8	synthesis	synthesis	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	but	but	_	_	_	_	_	_	_
11	not	not	_	_	_	_	_	_	_
12	p65	p65	_	_	_	_	_	_	_
13	mRNA	mrna	_	_	_	_	_	_	_
14	whose	whose	_	_	_	_	_	_	_
15	expression	expression	_	_	_	_	_	_	_
16	was	be	_	_	_	_	_	_	_
17	constitutive	constitutive	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	Interestingly	interestingly	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	all	all	_	_	_	_	_	_	_
4	those	those	_	_	_	_	_	_	_
5	early	early	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	late	late	_	_	_	_	_	_	_
8	events	event	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	but	but	_	_	_	_	_	_	_
11	not	not	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	immediate	immediate	_	_	_	_	_	_	_
14	ones	one	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	were	be	_	_	_	_	_	_	_
17	inhibited	inhibit	_	_	_	_	_	_	_
18	by	by	_	_	_	_	_	_	_
19	a	a	_	_	_	_	_	_	_
20	neutralizing	neutralize	_	_	_	_	_	_	_
21	anti-tumor	anti-tumor	_	_	_	_	_	_	_
22	necrosis	necrosis	_	_	_	_	_	_	_
23	factor	factor	_	_	_	_	_	_	_
24	alpha	alpha	_	_	_	_	_	_	_
25	(	(	_	_	_	_	_	_	_
26	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
27	)	)	_	_	_	_	_	_	_
28	monoclonal	monoclonal	_	_	_	_	_	_	_
29	antibody	antibody	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	Similarly	similarly	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	cycloheximide	cycloheximide	_	_	_	_	_	_	_
4	prevented	prevent	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	p65	p65	_	_	_	_	_	_	_
7	and	and	_	_	_	_	_	_	_
8	c-rel	c-rel	_	_	_	_	_	_	_
9	translocation	translocation	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	consequent	consequent	_	_	_	_	_	_	_
12	formation	formation	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	active	active	_	_	_	_	_	_	_
15	binding	binding	_	_	_	_	_	_	_
16	heterodimers	heterodimer	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	at	at	_	_	_	_	_	_	_
19	early	early	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	late	late	_	_	_	_	_	_	_
22	times	time	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	Cyclosporin	Cyclosporin	_	_	_	_	_	_	_
2	A	A	_	_	_	_	_	_	_
3	impaired	impair	_	_	_	_	_	_	_
4	not	not	_	_	_	_	_	_	_
5	only	only	_	_	_	_	_	_	_
6	early	early	_	_	_	_	_	_	_
7	and	and	_	_	_	_	_	_	_
8	late	late	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	but	but	_	_	_	_	_	_	_
11	also	also	_	_	_	_	_	_	_
12	immediate	immediate	_	_	_	_	_	_	_
13	events	event	_	_	_	_	_	_	_
14	;	;	_	_	_	_	_	_	_
15	however	however	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	addition	addition	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
20	prevented	prevent	_	_	_	_	_	_	_
21	all	all	_	_	_	_	_	_	_
22	inhibition	inhibition	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	indicate	indicate	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	regulation	regulation	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	NF-kappa	NF-kappa	_	_	_	_	_	_	_
9	B	B	_	_	_	_	_	_	_
10	activation	activation	_	_	_	_	_	_	_
11	during	during	_	_	_	_	_	_	_
12	T	t	_	_	_	_	_	_	_
13	cell	cell	_	_	_	_	_	_	_
14	activation	activation	_	_	_	_	_	_	_
15	by	by	_	_	_	_	_	_	_
16	TcR/CD3	tcr/cd3	_	_	_	_	_	_	_
17	signals	signal	_	_	_	_	_	_	_
18	is	be	_	_	_	_	_	_	_
19	biphasic	biphasic	_	_	_	_	_	_	_
20	:	:	_	_	_	_	_	_	_
21	TcR/CD3	TcR/CD3	_	_	_	_	_	_	_
22	triggers	trigger	_	_	_	_	_	_	_
23	its	its	_	_	_	_	_	_	_
24	immediate	immediate	_	_	_	_	_	_	_
25	translocation	translocation	_	_	_	_	_	_	_
26	,	,	_	_	_	_	_	_	_
27	which	which	_	_	_	_	_	_	_
28	is	be	_	_	_	_	_	_	_
29	transient	transient	_	_	_	_	_	_	_
30	if	if	_	_	_	_	_	_	_
31	no	no	_	_	_	_	_	_	_
32	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
33	is	be	_	_	_	_	_	_	_
34	present	present	_	_	_	_	_	_	_
35	.	.	_	_	_	_	_	_	_

1	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	therefore	therefore	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	emerges	emerge	_	_	_	_	_	_	_
6	as	as	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	main	main	_	_	_	_	_	_	_
9	factor	factor	_	_	_	_	_	_	_
10	responsible	responsible	_	_	_	_	_	_	_
11	for	for	_	_	_	_	_	_	_
12	a	a	_	_	_	_	_	_	_
13	second	second	_	_	_	_	_	_	_
14	phase	phase	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	NF-kappa	NF-kappa	_	_	_	_	_	_	_
17	B	B	_	_	_	_	_	_	_
18	regulation	regulation	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	controlling	control	_	_	_	_	_	_	_
21	both	both	_	_	_	_	_	_	_
22	translocation	translocation	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	p65	p65	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	c-rel	c-rel	_	_	_	_	_	_	_
27	,	,	_	_	_	_	_	_	_
28	and	and	_	_	_	_	_	_	_
29	new	new	_	_	_	_	_	_	_
30	mRNA	mrna	_	_	_	_	_	_	_
31	synthesis	synthesis	_	_	_	_	_	_	_
32	for	for	_	_	_	_	_	_	_
33	c-rel	c-rel	_	_	_	_	_	_	_
34	and	and	_	_	_	_	_	_	_
35	p105/p50	p105/p50	_	_	_	_	_	_	_
36	.	.	_	_	_	_	_	_	_

